Search Results - "Kasow, K A"

Secondary solid cancer screening following hematopoietic cell transplantation by Inamoto, Y, Shah, N N, Savani, B N, Shaw, B E, Abraham, A A, Ahmed, I A, Akpek, G, Atsuta, Y, Baker, K S, Basak, G W, Bitan, M, DeFilipp, Z, Gregory, T K, Greinix, H T, Hamadani, M, Hamilton, B K, Hayashi, R J, Jacobsohn, D A, Kamble, R T, Kasow, K A, Khera, N, Lazarus, H M, Malone, A K, Lupo-Stanghellini, M T, Margossian, S P, Muffly, L S, Norkin, M, Ramanathan, M, Salooja, N, Schoemans, H, Wingard, J R, Wirk, B, Wood, W A, Yong, A, Duncan, C N, Flowers, M E D, Majhail, N S

“…Hematopoietic stem cell transplant (HCT) recipients have a substantial risk of developing secondary solid cancers, particularly beyond 5 years after HCT and…”
Get full text

Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis by Cook, R J, Wang, Z, Arora, M, Lazarus, H M, Kasow, K A, Champagne, M A, Saber, W, van Besien, K M, Hale, G A, Copelan, E A, Elmongy, M, Ueno, N T, Horn, B N, Slavin, S, Bishop, M R, Stadtmauer, E A

“…Desmoplastic small round cell tumor of the peritoneum (DSRCTP) is a rare, frequently fatal tumor. This retrospective study, based on CIBMTR registry data,…”
Get full text

A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up by Kasow, K A, Stewart, C F, Barfield, R C, Wright, N L, Li, C, Srivastava, D K, Leung, W, Horwitz, E M, Bowman, L C, Handgretinger, R, Hale, G A

“…Fifty-eight consecutive children with high-risk malignancies were treated with CY, and targeted topotecan followed by autologous hematopoietic cell…”
Get full text

A novel approach for quantification of KIR expression in healthy donors and pediatric recipients of hematopoietic SCTs by Chen, X, Knowles, J, Barfield, R C, Kasow, K A, Madden, R, Woodard, P, Srivastava, D K, Horwitz, E M, Handgretinger, R, Hale, G A

“…The killer cell Ig-like receptor (KIR) expression repertoire may offer valuable information for hematopoietic SCT (HSCT). We designed a quantitative KIR…”
Get full text

Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms’ tumor: a CIBMTR retrospective analysis by Malogolowkin, M H, Hemmer, M T, Le-Rademacher, J, Hale, G A, Mehta, P A, Smith, A R, Kitko, C, Abraham, A, Abdel-Azim, H, Dandoy, C, Angel Diaz, M, Gale, R P, Guilcher, G, Hayashi, R, Jodele, S, Kasow, K A, MacMillian, M L, Thakar, M, Wirk, B M, Woolfrey, A, Thiel, E L

“…Despite the marked improvement in the overall survival (OS) for patients diagnosed with Wilms’ tumor (WT), the outcomes for those who experience relapse have…”
Get full text

Clinical gene-marking of mesenchymal cells by Horwitz, E.M., Kasow, K.A., Hofmann, T.J.

Get full text

Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience by Hale, G A, Arora, M, Ahn, K W, He, W, Camitta, B, Bishop, M R, Bitan, M, Cairo, M S, Chan, K, Childs, R W, Copelan, E, Davies, S M, Perez, M A D, Doyle, J J, Gale, R P, Vicent, M G, Horn, B N, Hussein, A A, Jodele, S, Kamani, N R, Kasow, K A, Kletzel, M, Lazarus, H M, Lewis, V A, Myers, K C, Olsson, R, Pulsipher, M, Qayed, M, Sanders, J E, Shaw, P J, Soni, S, Stiff, P J, Stadtmauer, E A, Ueno, N T, Wall, D A, Grupp, S A

“…Although the role of autologous hematopoietic cell transplantation (auto-HCT) is well established in neuroblastoma (NBL), the role of allogeneic HCT (allo-HCT)…”
Get full text

Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis by Farhadfar, Nosha, Murthy, Hemant S., Logan, Brent R., Sees, Jennifer A., Ayas, Mouhab, Battiwalla, Minoo, Beitinjaneh, Amer M., Chhabra, Saurabh, Diaz, Miguel Angel, Engles, Katie, Frangoul, Haydar, Ganguly, Siddhartha, Gergis, Usama, Kamani, Nayesh R., Kamble, Rammurti T., Kasow, Kimberly A., Lazarus, Hillard M., Liesveld, Jane L., Norkin, Maxim, O’ Donnell, Paul V., Olsson, Richard F., Rossmann, Susan, Savani, Bipin N., Schears, Raquel, Seo, Sachiko, Solh, Melhem M., Spitzer, Thomas, Sugrue, Michele, Yared, Jean A., Linenberger, Michael, Schwartz, Joseph, Pulsipher, Michael A., Shah, Nirali N., Switzer, Galen E., Confer, Dennis L., Shaw, Bronwen E., Wingard, John R.

“…Pre-harvest autologous blood collection from bone marrow (BM) donors is performed to meet potential post-operative transfusion needs. This study examines the…”
Get full text

SNX10 mutations define a subgroup of human autosomal recessive osteopetrosis with variable clinical severity by Pangrazio, Alessandra, Fasth, Anders, Sbardellati, Andrea, Orchard, Paul J, Kasow, Kimberly A, Raza, Jamal, Albayrak, Canan, Albayrak, Davut, Vanakker, Olivier M, De Moerloose, Barbara, Vellodi, Ashok, Notarangelo, Luigi D, Schlack, Claire, Strauss, Gabriele, Kühl, Jörn‐Sven, Caldana, Elena, Lo Iacono, Nadia, Susani, Lucia, Kornak, Uwe, Schulz, Ansgar, Vezzoni, Paolo, Villa, Anna, Sobacchi, Cristina

“…Human Autosomal Recessive Osteopetrosis (ARO) is a genetically heterogeneous disorder caused by reduced bone resorption by osteoclasts. In 2000, we found that…”
Get full text

Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients by YUSUF, Usman, HALE, Gregory A, HANDGRETINGER, Rupert, HOYDEN, Randall T, CARR, Jeanne, ZHENGMING GU, BENAIM, Ely, WOODARD, Paul, KASOW, Kimberly A, HORWITZ, Edwin M, LEUNG, Wing, DEO KUMAR SRIVASTAVA

“…Adenovirus (ADV) infections are associated with significant morbidity and mortality after hematopoietic stem cell transplantation (HSCT). The virus is endemic…”
Get full text

Human CD4+CD25+ Regulatory T Cells Share Equally Complex and Comparable Repertoires with CD4+CD25- Counterparts by Kasow, Kimberly A, Chen, Xiaohua, Knowles, James, Wichlan, David, Handgretinger, Rupert, Riberdy, Janice M

“…CD4(+)CD25(+) T cells are critical mediators of peripheral immune tolerance. However, many developmental and functional characteristics of these cells are…”
Get full text

Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report by Khandelwal, Pooja, Millard, Heather R., Thiel, Elizabeth, Abdel-Azim, Hisham, Abraham, Allistair A., Auletta, Jeffery J., Boulad, Farid, Brown, Valerie I., Camitta, Bruce M., Chan, Ka Wah, Chaudhury, Sonali, Cowan, Morton J., Angel-Diaz, Miguel, Gadalla, Shahinaz M., Gale, Robert Peter, Hale, Gregory, Kasow, Kimberly A., Keating, Amy K., Kitko, Carrie L., MacMillan, Margaret L., Olsson, Richard F., Page, Kristin M., Seber, Adriana, Smith, Angela R., Warwick, Anne B., Wirk, Baldeep, Mehta, Parinda A.

“…•In patients with leukemia, acute lymphoblastic leukemia in second complete remission was the most common indication for allogeneic…”
Get full text

Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age by Vrooman, Lynda M, Millard, Heather R, Brazauskas, Ruta, Majhail, Navneet S, Battiwalla, Minoo, Flowers, Mary E, Savani, Bipin N, Akpek, Görgün, Aljurf, Mahmoud, Bajwa, Rajinder, Baker, K. Scott, Beitinjaneh, Amer, Bitan, Menachem, Buchbinder, David, Chow, Eric, Dandoy, Christopher, Dietz, Andrew C, Diller, Lisa, Gale, Robert Peter, Hashmi, Shahrukh K, Hayashi, Robert J, Hematti, Peiman, Kamble, Rammurti T, Kasow, Kimberly A, Kletzel, Morris, Lazarus, Hillard M, Malone, Adriana K, Marks, David I, O'Brien, Tracey A, Olsson, Richard F, Ringden, Olle, Seo, Sachiko, Steinberg, Amir, Yu, Lolie C, Warwick, Anne, Shaw, Bronwen, Duncan, Christine

“…Highlights • The 10-year overall survival estimate for those who survived free of relapse ≥1 year after hematopoietic cell transplantation was 87%. • Thirty…”
Get full text

The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time by Prokopishyn, Nicole L., Logan, Brent R., Kiefer, Deidre M., Sees, Jennifer A., Chitphakdithai, Pintip, Ahmed, Ibrahim A., Anderlini, Paolo N., Beitinjaneh, Amer M., Bredeson, Christopher, Cerny, Jan, Chhabra, Saurabh, Daly, Andrew, Diaz, Miguel Angel, Farhadfar, Nosha, Frangoul, Haydar A., Ganguly, Siddhartha, Gastineau, Dennis A., Gergis, Usama, Hale, Gregory A., Hematti, Peiman, Kamble, Rammurti T., Kasow, Kimberly A., Lazarus, Hillard M., Liesveld, Jane L., Murthy, Hemant S., Norkin, Maxim, Olsson, Richard F., Papari, Mona, Savani, Bipin N., Szer, Jeffrey, Waller, Edmund K., Wirk, Baldeep, Yared, Jean A., Pulsipher, Michael A., Shah, Nirali N., Switzer, Galen E., O'Donnell, Paul V., Confer, Dennis L., Shaw, Bronwen E.

“…Bone marrow (BM) is an essential source of hematopoietic stem cell grafts for many allogeneic hematopoietic cell transplant (HCT) recipients, including adult…”
Get full text

Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning by Ringdén, Olle, Brazauskas, Ruta, Wang, Zhiwei, Ahmed, Ibrahim, Atsuta, Yoshiko, Buchbinder, David, Burns, Linda J, Cahn, Jean-Yves, Duncan, Christine, Hale, Gregory A, Halter, Joerg, Hayashi, Robert J, Hsu, Jack W, Jacobsohn, David A, Kamble, Rammurti T, Kamani, Naynesh R, Kasow, Kimberly A, Khera, Nandita, Lazarus, Hillard M, Loren, Alison W, Marks, David I, Myers, Kasiani C, Ramanathan, Muthalagu, Saber, Wael, Savani, Bipin N, Schouten, Harry C, Socie, Gérard, Sorror, Mohamed L, Steinberg, Amir, Popat, Uday, Wingard, John R, Mattsson, Jonas, Majhail, Navneet S

“…Abstract We examined risk of second solid cancers after allogeneic hematopoietic cell transplantation (AHCT) using reduced-intensity/nonmyeloablative…”
Get full text

58-W: Hematopoietic stem cell transplantation for immune dysregulation, polyendocrinopathy X-linked syndrome (IPEX) by Embrey, Christy M, Kasow, Kimberly A, Riberdy, Janice M, Conley, Mary Ellen, Turner, E. Victoria

Get full text

Malignant infantile osteopetrosis & primary pulmonary hypertension: A new combination? by Kasow, Kimberly A., Bonfim, Carmem, Asch, Julie, Margolis, David A., Jenkins, Jesse, Tamburro, Robert F., Handgretinger, Rupert, Horwitz, Edwin M.

“…Malignant infantile osteopetrosis (MIOP), a rare genetic disorder of the osteoclast, is fatal without hematopoietic stem cell transplantation. Primary…”
Get full text

Possible allogeneic graft-versus-tumor effect in childhood melanoma by KASOW, Kimberly A, HANDGRETINGER, Rupert, KRASIN, Matthew J, PAPPO, Alberto S, WING LEUNG

“…Patients with metastatic melanoma have a very poor prognosis despite contemporary biochemotherapy. A 14-year-old girl with stage IV melanoma and brain…”
Get full text

Survival and Late Effects of Children Undergoing Myeloablative Allogeneic HCT at Less Than Three Years of Age: A Report from the Center for International Blood and Marrow Transplant Research by Vrooman, Lynda, MD, MSc, Millard, Heather, MPH, Brazauskas, Ruta, PhD, Majhail, Navneet S., MD, MS, Battiwalla, Minoo, MD, MS, Flowers, Mary E.D., MD, Savani, Bipin N., MD, Akpek, Görgün, MD, MHS, Aljurf, Mahmoud D., MD, MPH, Bajwa, Rajinder, MBBS, MRCP, MD, Baker, K. Scott, MD, MS, Beitinjaneh, Amer, MD, MPH, MS, Bitan, Menachem, MD, PhD, Buchbinder, David, MD, Dandoy, Christopher E., MD, MSc, Gale, Robert Peter, MD, PhD, Hayashi, Robert J., MD, Hematti, Peiman, MD, Kamble, Rammurti T., MD, Kasow, Kimberly A., DO, Kletzel, Morris, MD, FAAP, MBA, Lazarus, Hillard M., MD, Malone, Adriana K., MD, O'Brien, Tracey, MD, Olsson, Richard, MD, PhD, Reddy, Vijay, MD, PhD, Willert, Jennifer Reikes, MD, Ringden, Olle, MD, PhD, Schears, Raquel M., MD, MPH, FACEP, Seo, Sachiko, MD, PhD, Steinberg, Amir, MD, Yu, Lolie C., MD, Shaw, Bronwen E., MD, PhD, Duncan, Christine, MD

Get full text